Search results
Search for "circular dichroism" in Full Text gives 139 result(s) in Beilstein Journal of Organic Chemistry.
Design of a novel tryptophan-rich membrane-active antimicrobial peptide from the membrane-proximal region of the HIV glycoprotein, gp41
- Evan F. Haney,
- Leonard T. Nguyen,
- David J. Schibli and
- Hans J. Vogel
Beilstein J. Org. Chem. 2012, 8, 1172–1184, doi:10.3762/bjoc.8.130
- observed antimicrobial effects. Circular dichroism spectroscopy The backbone conformations of all of the gp41 peptide derivatives were examined by using far-UV circular dichroism (CD) spectroscopy. The resulting CD spectra of the peptides in buffer, SDS, DPC and 50% trifluoroethanol (TFE) are shown in
- previous scan, indicating that equilibrium had been reached. Circular dichroism spectroscopy CD spectra were collected at room temperature on a Jasco J815 spectropolarimeter by using a 0.1 cm path length cuvette. Far-UV spectra of 50 μM peptide solutions were collected between 190–260 nm with a 0.5 nm step
Graphical Abstract
Figure 1: (A) Names and sequences of the gp41w-derived peptides. (B) Helical-wheel projections of gp41w, gp41...
Figure 2: (A) Normalized Trp emission spectra of the gp41w derivatives in buffer. The spectra have been norma...
Figure 3: Relative Ksv values calculated for gp41w, gp41w-4R, gp41w-KA and gp41w-FKA in buffer and in the pre...
Figure 4: Percent calcein leakage induced by the gp41 derivatives. Gp41w (blue), gp41w-4R (orange), gp41w-KA ...
Figure 5: DSC thermograms of pure zwitterionic DPPC (left) and anionic DPPG (right) lipid suspensions compare...
Figure 6: Far-UV CD spectra of gp41w and the three derivative peptides. The panel on the left shows the pepti...
Figure 7: NMR solution structure of gp41w-4R, gp41w-KA and gp41w-FKA in the cosolvent mixture. Overlay of the...
Partial thioamide scan on the lipopeptaibiotic trichogin GA IV. Effects on folding and bioactivity
- Marta De Zotti,
- Barbara Biondi,
- Cristina Peggion,
- Matteo De Poli,
- Haleh Fathi,
- Simona Oancea,
- Claudio Toniolo and
- Fernando Formaggio
Beilstein J. Org. Chem. 2012, 8, 1161–1171, doi:10.3762/bjoc.8.129
- activity. In each analogue, the single ψ[CS-NH] group was strategically incorporated either at an internal position of the amino-acid sequence, ψ[CS-NH]5, or near each of the two ends, ψ[CS-NH]2 and ψ[CS-NH]9. Moreover, the preferred conformations of these analogues were investigated by circular dichroism
- Information File 1. Circular dichroism The CD spectra were measured on a Jasco (Tokyo, Japan) model J-715 spectropolarimeter equipped with a Haake thermostat (Thermo Fisher Scientific, Waltham, MA). Baselines were corrected by subtracting the solvent contribution. Fused quartz cells of 1.0 mm and 10.0 mm path
Graphical Abstract
Figure 1: List of primary structures and abbreviations for the peptides studied in this work. The [Leu11-OMe]...
Scheme 1: Synthesis of ψ[CS-NH]2. 1: Coupling in the presence of EDC/HOBt. 2: Deprotection by using TFA/DCM. ...
Scheme 2: Synthesis of ψ[CS-NH]5. 1: Coupling in the presence of EDC/HOBt. 2: Deprotection by using TFA/DCM. ...
Scheme 3: Synthesis of ψ[CS-NH]9. 1: Deprotection by catalytic hydrogenation with Pd/C. 2: Coupling with n-Oc...
Figure 2: RP-HPLC profiles obtained for [Leu11-OMe] trichogin GA IV (tric-OMe) and its ψ[CS-NH]2, ψ[CS-NH]5, ...
Figure 3: Far-UV (panel I) and near-UV (panel II) CD spectra of [Leu11-OMe] trichogin GA IV (tric-OMe) and it...
Figure 4: FT-IR absorption spectra (3550–3200 cm−1 region) in CDCl3 solution of [Leu11-OMe] trichogin GA IV (...
Figure 5: Region of the amide NH protons in the H/H-ROESY spectrum of ψ[CS-NH]9 (400 MHz, 1 mM in CD3CN solut...
Figure 6: Fingerprint region of the H/H-ROESY spectrum of ψ[CS-NH]9 (400 MHz, 1 mM in CD3CN solution, 298 K)....
Figure 7: Fingerprint region of the H/H-ROESY spectrum of ψ[CS-NH]9 (400 MHz, 1 mM in CD3CN solution, 298 K)....
Figure 8: Ribbon representation of the lowest energy (138.7 kcal/mol) 3D structure obtained for ψ[CS-NH]9. Al...
Control over molecular motion using the cis–trans photoisomerization of the azo group
- Estíbaliz Merino and
- María Ribagorda
Beilstein J. Org. Chem. 2012, 8, 1071–1090, doi:10.3762/bjoc.8.119
- conformational changes in polymers. There may also be variations in the organization of large assemblies of molecules in gels or liquid crystals. When polarized light is used, the photoisomerization often induces a reorganization of chromophores that can be reflected in the circular dichroism spectra. The basic
- , 15 min) again enriches 46% of the trans isomer. The molecular motion was studied by circular dichroism (CD), 1H NMR and DFT calculations confirming that the change in the configuration of the N=N double bond modifies the initial position of the ferrocene resulting in an opening (cis) and closing
- standard techniques (UV–vis, circular dichroism, chiral HPLC and NMR) has established that the chiral optical response differs greatly depending on the position of the sulfoxide group (C-2 or C-3). Cis isomers in both p-tolylsulfinyl azocompounds show an opposite arrangement of substituents around the N=N
Graphical Abstract
Figure 1: Photoisomerization process of azobenzene.
Figure 2: Representative example of an UV spectrum of an azocompound of the azobenzene type (blue line: trans...
Figure 3: Mechanistic proposals for the isomerization of azobenzenes.
Figure 4: Representation of the photocontrol of a K+ channel in the cellular membrane based on the isomerizat...
Figure 5: (a) MAG interaction with iGluR; (b) photocontrol of the opening of the ion channel by trans–cis iso...
Figure 6: Photocontrol of the structure of the α-helix in the polypeptide azoderivative 2. Reprinted (adapted...
Figure 7: Recognition of a guanidinium ion by a cis,cis-bis-azo derivative 3.
Figure 8: Recognition of cesium ions by cis-azo derivative 4.
Figure 9: Photocontrolled formation of an inclusion complex of cyclodextrin trans-azo 5+6.
Figure 10: Pseudorotaxane-based molecular machine.
Figure 11: Molecular hinge. Reprinted (adapted) with permission from Org. Lett. 2004, 6, 2595–2598. Copyright ...
Figure 12: Molecular threader. Reprinted (adapted) with permission from Acc. Chem. Res. 2001, 34, 445–455. Cop...
Figure 13: Molecular scissors based on azobenzene 12. Reprinted (adapted) with permission from J. Am. Chem. So...
Figure 14: Molecular pedals. Reprinted by permission from Macmillan Publishers Ltd: Nature, 2006, 440, 512–515...
Figure 15: Design of nanovehicles based on azo structures. Reprinted (adapted) with permission from Org. Lett. ...
Figure 16: Light-activated mesostructured silica nanoparticles (LAMs).
Figure 17: Molecular lift.
Figure 18: Conformational considerations in mono-ortho-substituted azobenzenes.
Scheme 1: Synthesis and photoisomerization of sulfinyl azobenzenes. Reprinted (adapted) with permission from ...
Figure 19: Photoisomerization of azocompound 22 and its application as a photobase catalyst.
Figure 20: Effect of irradiation with linearly polarized light on azo-LCEs. Reprinted by permission from Macmi...
Figure 21: Chemically and photochemically triggered memory switching cycle of the [2]rotaxane 25.
Figure 22: Unidirectional photoisomerization process of the azobenzene 26.
Investigation of the network of preferred interactions in an artificial coiled-coil association using the peptide array technique
- Raheleh Rezaei Araghi,
- Carsten C. Mahrenholz,
- Rudolf Volkmer and
- Beate Koksch
Beilstein J. Org. Chem. 2012, 8, 640–649, doi:10.3762/bjoc.8.71
- on a C-8 column (Phenomenex® Luna C8, 10 μM, 250 mm × 21.2 mm). The identities of peptides were confirmed using an ESI–TOF instrument. Circular-dichroism (CD) spectroscopy [18]: Peptide samples were analyzed in 10 mM phosphate buffer (pH 7.4). Far-ultraviolet circular-dichroism spectra and GndHCl
Graphical Abstract
Figure 1: (a) Helical wheel representation of the tetrameric Acid-pp/B3β2γ helix bundle, (b) sequences of Aci...
Figure 2: (a) Sequence for random mutation resulting in 1764 spots. The randomized positions are denoted by Xa...
Figure 3: Glycine scanning of Acid-pp sequences. The substituted glycines are highlighted in red. Each sequen...
Figure 4: Heat-map diagrams depicting the quantitatively measured SIs for Acid-pp sequences containing mutati...
Figure 5: (a) The complete sequences of the selected α-mutants. (b) CD and (c) thermal denaturation spectra o...
Figure 6: Size-exclusion chromatograms of equimolar mixtures of B3β2γ with (a) Acid-pp, (b) VaVdEeEg, (c) LaLd...
Conserved and species-specific oxylipin pathways in the wound-activated chemical defense of the noninvasive red alga Gracilaria chilensis and the invasive Gracilaria vermiculophylla
- Martin Rempt,
- Florian Weinberger,
- Katharina Grosser and
- Georg Pohnert
Beilstein J. Org. Chem. 2012, 8, 283–289, doi:10.3762/bjoc.8.30
- , 5 and 6 were optically inactive and exhibited no signal in circular dichroism measurements. Both isomers 5 and 6 were already detected in the crude extracts, but also after work-up and during storage in CDCl3 further isomerization was observed. The biosynthetic origin of 5 and 6 from arachidonic
- equipped with a Synergi MAX-RP 250 × 4.6 mm column (particle size 4 µm) from Phenomenex (Macclesfield, UK). Optical rotations were measured on a Jasco (Groß-Umstadt, Germany) 1030 polarimeter at 589 nm. Circular-dichroism spectra were recorded on a Jasco P810 instrument. Analytical thin-layer
Graphical Abstract
Figure 1: UPLC–ESIMS-based metabolic profiles of Gracilaria vermiculophylla (A) and Gracilaria chilensis (B) ...
Scheme 1: 5-((1E,3,5E,7Z,10Z)-hexadeca-1,3,5,7,10-pentaenyl)dihydrofuran-2(3H)-one (5) with 1H–1H COSY (bold ...
Scheme 2: Suggested pathway for the biosynthesis of 5.
Figure 2: Relative risk (mean ± 95% confidence interval) of Echinolittorina peruviana attachment on surfaces ...
Fifty years of oxacalix[3]arenes: A review
- Kevin Cottet,
- Paula M. Marcos and
- Peter J. Cragg
Beilstein J. Org. Chem. 2012, 8, 201–226, doi:10.3762/bjoc.8.22
- effect that occurred when the cations bound to the lower-rim esters, as indicated by increasingly complex 1H NMR patterns. When 46 bound to S-2-methylbutylammonium triflate, the presence of a chiral complex was confirmed by circular dichroism [53]. 4 Oxacalix[3]arene complexes 4.1 Complexation by parent
Graphical Abstract
Figure 1: Calixarenes and expanded calixarenes: p-tert-Butylcalix[4]arene (1), p-tert-butyldihomooxacalix[4]a...
Figure 2: Conventional nomenclature for oxacalix[n]arenes.
Scheme 1: Synthesis of oxacalix[3]arenes: (i) Formaldehyde (37% aq), NaOH (aq), 1,4-dioxane; glacial acetic a...
Figure 3: p-tert-Butyloctahomotetraoxacalix[4]arene (4a) [16].
Figure 4: X-ray crystal structure of 3a showing phenolic hydrogen bonding (IUCr ID AS0508) [17].
Scheme 2: Stepwise synthesis of asymmetric oxacalix[3]arenes: (i) MOMCl, Adogen®464; (ii) 2,2-dimethoxypropan...
Figure 5: X-ray crystal structure of heptahomotetraoxacalix[3]arene 5 (CCDC ID 166088) [21].
Scheme 3: Oxacalix[3]arene synthesis by reductive coupling: (i) Me3SiOTf, Et3SiH, CH2Cl2; R1, R2 = I, Br, ben...
Scheme 4: Oxacalix[3]naphthalene: (i) HClO4 (aq), wet CHCl3 (R = tert-butyl, 6a, H, 6b) [20].
Figure 6: Conformers of 3a.
Scheme 5: Origin of the 25:75 cone:partial-cone statistical distribution of O-substituted oxacalix[3]arenes (p...
Scheme 6: Synthesis of alkyl ethers 7–10: (i) Alkyl halide, NaH, DMF [24].
Scheme 7: Synthesis of a pyridyl derivative 11a: (i) Picolyl chloride hydrochloride, NaH, DMF [26,27].
Figure 7: X-ray crystal structure of partial-cone 11a (CCDC ID 150580) [26].
Scheme 8: Lower-rim ethyl ester synthesis: (i) Ethyl bromoacetate, NaH, t-BuOK or alkali metal carbonate, THF...
Scheme 9: Forming chiral receptor 13: (i) Ethyl bromoacetate, NaH, THF; (ii) NaOH, H2O/1,4-dioxane; (iii) S-P...
Figure 8: X-ray crystal structure of 16 (IUCr ID PA1110) [32].
Scheme 10: Lower rim N,N-diethylamide 17a: (i) N,N-Diethylchloroacetamide, NaH, t-BuOK or alkali metal carbona...
Scheme 11: Capping the lower rim: (i) N,N-Diethylchloroacetamide, NaH, THF; (ii) NaOH, H2O/1,4-dioxane; (iii) ...
Figure 9: X-ray crystal structure of 18 (CCDC ID 142599) [33].
Scheme 12: Extending the lower rim: (i) Glycine methyl ester, HOBt, dicyclohexycarbodiimide (DCC), CH2Cl2; (ii...
Scheme 13: Synthesis of N-hydroxypyrazinone derivative 23: (i) 1-[3-(Dimethylamino)propyl]-3-ethylcarbodiimide...
Scheme 14: Synthesis of 24: (i) 1-Adamantyl bromomethyl ketone, NaH, THF [39].
Scheme 15: Synthesis of 25 and 26: (i) (Diphenylphosphino)methyl tosylate, NaH, toluene; (ii) phenylsilane, to...
Figure 10: X-ray crystal structure of 27 in the partial-cone conformer (CCDC ID SUP 90399) [41].
Scheme 16: Synthesis of strapped oxacalix[3]arene derivatives 28 and 29: (i) N,N’-Bis(chloroacetyl)-1,2-ethyle...
Figure 11: A chiral oxacalix[3]arene [45].
Figure 12: X-ray crystal structure of asymmetric oxacalix[3]arene 30 incorporating t-Bu, iPr and Et groups (CC...
Scheme 17: Reactions of an oxacalix[3]arene incorporating an upper-rim Br atom with (i) Pd(OAc)2, PPh3, HCO2H,...
Scheme 18: Synthesis of acid 39: (i) NaOH, EtOH/H2O, HCl (aq) [47].
Figure 13: Two forms of dimeric oxacalix[3]arene 40 [47].
Scheme 19: Capping the upper rim: (i) t-BuLi, THF, −78 °C; (ii) NaBH4, THF/EtOH; (iii) 1,3,5-tris(bromomethyl)...
Figure 14: Oxacalix[3]arene capsules 46 and 47 formed through coordination chemistry [52,53].
Figure 15: X-ray crystal structure of the 3b-vanadyl complex (CCDC ID 240185) [57].
Scheme 20: Effect of Ti(IV)/SiO2 on 3a: (i) Ti(OiPr)4, toluene; (ii) triphenylsilanol, toluene; (iii) partiall...
Figure 16: X-ray crystal structures of oxacalix[3]arene complexes with rhenium: 3b∙Re(CO)3 (CCDC ID 620981, le...
Figure 17: X-ray crystal structure of the La2·3a2 complex (CSD ID TIXXUT) [60].
Figure 18: X-ray crystal structures of [3a∙UO2]− with a cavity-bound cation (CCDC ID 135575, left) and without...
Figure 19: X-ray crystal structure of a supramolecule comprising two [3g·UO2]− complexes that encapsulate a di...
Figure 20: X-ray crystal structure of oxacalix[3]arene 49 capable of chiral selectivity (CSD ID HIGMUF) [65].
Figure 21: The structure of derivative 50 incorporating a Reichardt dye [66].
Figure 22: Phosphorylated oxacalix[3]arene complexes with transition metals: (Left to right) 26∙Au, 26∙Mo(CO)3...
Figure 23: X-ray crystal structure of [17a·HgCl2]2 (CCDC ID 168653) [69].
Figure 24: X-ray crystal structures of 3f with C60 (CCDC ID 182801, left) [76] and a 1,4-bis(9-fluorenyl) C60 deri...
Figure 25: X-Ray crystal structure of 3i and 6a encapsulating C60 (CCDC ID 102473 and 166077) [23,79].
Figure 26: A C60 complexing cationic oxacalix[3]arene 51 [81].
Figure 27: An oxacalix[3]arene-C60 self-associating system 53 [87].
Scheme 21: Synthesis of fluorescent pyrene derivative 55: (i) Propargyl bromide, acetone; (ii) CuI, 1-azidomet...
Scheme 22: Synthesis of responsive rhodamine derivative 57: (i) DCC, CH2Cl2 [91].
Scheme 23: Synthesis of nitrobenzyl derivative 58: (i) 1-Bromo-4-nitrobenzyl acetate, K2CO3, refluxing acetone...
Figure 28: X-ray crystal structure of [Na2∙17a](PF6)2 (CCDC ID 116656) [97].
Supramolecular FRET photocyclodimerization of anthracenecarboxylate with naphthalene-capped γ-cyclodextrin
- Qian Wang,
- Cheng Yang,
- Gaku Fukuhara,
- Tadashi Mori,
- Yu Liu and
- Yoshihisa Inoue
Beilstein J. Org. Chem. 2011, 7, 290–297, doi:10.3762/bjoc.7.38
- behavior of anthracenecarboxylate (AC) moieties. UV–vis, circular dichroism and fluorescence spectral studies revealed that two AC molecules are simultaneously included in the modified γ-CD cavity to form a right-handed screw and also that the naphthalene cap efficiently transfers the singlet energy to AC
- carbonate. In contrast, capped γ-CD 6 showed a much higher solubility in water, as the naphthalene cap can hardly interact with another CD. The complexation behavior of AC with modified γ-CDs 6 and 7 was investigated by UV–vis, circular dichroism and fluorescence spectral studies. As shown in Figure 1, the
- addition of 7 to an aqueous solution of AC (0.2 mM) caused an evident bathochromic shift of the 1La band of AC, which is probably due to the stacking complexation of two AC molecules in a single γ-CD cavity. Modified γ-CDs 6 and 7 showed moderate circular dichroism signals in the naphthalene-absorbing
Graphical Abstract
Scheme 1: Biphenyl-capped (5), naphthalene-capped (6), and naphthalene-appended γ-cyclodextrin (7).
Figure 1: UV–vis spectral changes of 0.2 mM AC upon increasing the concentration of 7 in pH 9 phosphate buffe...
Figure 2: Circular dichroism spectra of 7 (0.2 mM) in the presence of 0, 0.0083, 0.025, 0.048, 0.071, 0.093, ...
Figure 3: Circular dichroism spectra of 6 (0.2 mM) in the presence of 0, 0.0083, 0.025, 0.048, 0.071, 0.093, ...
Figure 4: UV–vis spectra of AC (black dashed line) and 7 (red dashed line) and fluorescence spectra of 7 (0.0...
Miniemulsion polymerization as a versatile tool for the synthesis of functionalized polymers
- Daniel Crespy and
- Katharina Landfester
Beilstein J. Org. Chem. 2010, 6, 1132–1148, doi:10.3762/bjoc.6.130
- with a water-soluble catalyst [72]. The reaction was faster when the oil-soluble catalyst was used. Finally, helical substituted polyacetylene could be efficiently polymerized in direct miniemulsion to yield a latex displaying intense circular dichroism [73]. Particles from 60 to 400 nm could be
Graphical Abstract
Figure 1: Copolymerization of 2 monomers A and B with different polarities in direct miniemlusions with the d...
Figure 2: Interfacial alternating radical copolymerization between dibutyl maleate and vinyl gluconamide for ...
Figure 3: Chemical structures of the surfmers for radical polymerization in miniemulsions: a: sodium vinylben...
Scheme 1: Synthesis of the macroinitiator for ROMP in direct miniemulsion [71].
Figure 4: Monomers used in ionic miniemulsion polymerization. a: octamethylcyclotetrasiloxane [9,74], b: 1,3,5-tris...
Figure 5: Enzymatic reactions in miniemulsion droplets (reproduced with permission from [91]. Copyright (2003) Wi...
Figure 6: Chemical structure of a: polyaniline (leucoemeraldine), b: polypyrrole, c: poly(ethylene dioxythiop...
Figure 7: Transmission electron micrograph of polyurethane capsules synthesized by interfacial polyaddition i...
Figure 8: Schematics for the polycondensation reaction between hydrophobic alcohols and carboxylic acids surr...
Scheme 2: Polyimide from the reaction performed in the ionic liquid 1-ethyl-3-methylimidazolium bis(trifluoro...
Figure 9: a: TEM micrograph of the cubic structures, b: proposed mechanism for the production of the nanocube...
Gelation or molecular recognition; is the bis-(α,β-dihydroxy ester)s motif an omnigelator?
- Peter C. Griffiths,
- David W. Knight,
- Ian R. Morgan,
- Amy Ford,
- James Brown,
- Ben Davies,
- Richard K. Heenan,
- Stephen M. King,
- Robert M. Dalgliesh,
- John Tomkinson,
- Stuart Prescott,
- Ralf Schweins and
- Alison Paul
Beilstein J. Org. Chem. 2010, 6, 1079–1088, doi:10.3762/bjoc.6.123
- based on hydrogen bonding of the end-group was confirmed by IR and circular dichroism (CD) spectroscopic characterisation. The specific stereochemistry of the gelator end-groups is a crucial factor, providing an obvious analogy to molecular recognition phenomena. Small-angle neutron scattering provided
Graphical Abstract
Figure 1: Schröder–van Laar analysis for the melting of toluene (open symbols) and ethanol/water (filled symb...
Figure 2: SANS from 50 mg ml−1 G6 in a range of solvents, 25 °C; d-acetone (circles), d-chloroform (triangles...
Figure 3: SANS from G6 25 °C in d-toluene as a function of G6 concentration; 5 mg ml−1 (circles), 10 mg ml−1 ...
Figure 4: SANS from a series of homologous gelators, G5 (circles), G6 (squares) and G8 (triangles) in d-tolue...
Figure 5: SANS from 50 mg ml−1 G6 in d-toluene, 25 °C; hydrogenous gelator (empty symbols) and partially deut...
Figure 6: SANS from 35 mg ml−1 G6 in 75% d-ethanol/25% D2O, 37 °C; hydrogenous gelator (empty symbols) and pa...
Figure 7: SESANS data for 50 mg ml−1 G6 in deuterated toluene, 25 °C.
Figure 8: Inelastic neutron spectroscopy from toluene gels (upper Figure): red deuterated toluene/hydrogenous...
Figure 9: Inelastic neutron spectroscopy from cyclohexane gels (upper Figure): red deuterated cyclohexane/hyd...
Scheme 1: Synthesis of hydrogenous gelators.
Scheme 2: Structure of partially deuterated gelators.
Molecular recognition of organic ammonium ions in solution using synthetic receptors
- Andreas Späth and
- Burkhard König
Beilstein J. Org. Chem. 2010, 6, No. 32, doi:10.3762/bjoc.6.32
Graphical Abstract
Figure 1: Biologically important amines and quaternary ammonium salts: histamine (1), dopamine (2) and acetyl...
Figure 2: Crown ether 18-crown-6.
Figure 3: Conformations of 18-crown-6 (4) in solvents of different polarity.
Figure 4: Binding topologies of the ammonium ion depending on the crown ring size.
Figure 5: A “pseudorotaxane” structure consisting of 24-crown-8 and a secondary ammonium ion (5); R = Ph.
Figure 6: Typical examples of azacrown ethers, cryptands and related aza macrocycles.
Figure 7: Binding of ammonium to azacrown ethers and cryptands [111-113].
Figure 8: A 19-crown-6-ether with decalino blocking groups (11) and a thiazole-dibenzo-18-crown-6-ether (12).
Figure 9: 1,3-Bis(6-oxopyridazin-1-yl)propane derivatives 13 and 14 by Campayo et al.
Figure 10: Fluorescent azacrown-PET-sensors based on coumarin.
Figure 11: Two different pyridino-cryptands (17 and 18) compared to a pyridino-crown (19); chiral ammonium ion...
Figure 12: Pyridino-18-crown-6 ligand (21), a similar acridino-18-crown-6 ligand (22) and a structurally relat...
Figure 13: Ciral pyridine-azacrown ether receptors 24.
Figure 14: Chiral 15-crown-5 receptors 26 and an analogue 18-crown-6 ligand 27 derived from amino alcohols.
Figure 15: C2-symmetric chiral 18-crown-6 amino alcohol derivatives 28 and related macrocycles.
Figure 16: Macrocycles with diamide-diester groups (30).
Figure 17: C2-symmetric chiral aza-18-crown-6 ethers (31) with phenethylamine residues.
Figure 18: Chiral C-pivot p-methoxy-phenoxy-lariat ethers.
Figure 19: Chiral lariat crown ether 34.
Figure 20: Sucrose-based chiral crown ether receptors 36.
Figure 21: Permethylated fructooligosaccharide 37 showing induced-fit chiral recognition.
Figure 22: Biphenanthryl-18-crown-6 derivative 38.
Figure 23: Chiral lariat crown ethers derived from binol by Fuji et al.
Figure 24: Chiral phenolic crown ether 41 with “aryl chiral barriers” and guest amines.
Figure 25: Chiral bis-crown receptor 43 with a meso-ternaphthalene backbone.
Figure 26: Chromogenic pH-dependent bis-crown chemosensor 44 for diamines.
Figure 27: Triamine guests for binding to receptor 44.
Figure 28: Chiral bis-crown phenolphthalein chemosensors 46.
Figure 29: Crown ether amino acid 47.
Figure 30: Luminescent receptor 48 for bis-alkylammonium guests.
Figure 31: Luminescent CEAA (49a), a bis-CEAA receptor for amino acids (49b) and the structure of lysine bindi...
Figure 32: Luminescent CEAA tripeptide for binding small peptides.
Figure 33: Bis crown ether 51a self assembles co-operatively with C60-ammonium ion 51b.
Figure 34: Triptycene-based macrotricyclic dibenzo-[24]-crown-8 ether host 52 and guests.
Figure 35: Copper imido diacetic acid azacrown receptor 53a and the suggested His-Lys binding motif; a copper ...
Figure 36: Urea (54) and thiourea (55) benzo crown receptor for transport and extraction of amino acids.
Figure 37: Crown pyryliums ion receptors 56 for amino acids.
Figure 38: Ditopic sulfonamide bridged crown ether receptor 57.
Figure 39: Luminescent peptide receptor 58.
Figure 40: Luminescent receptor 59 for the detection of D-glucosamine hydrochloride in water/ethanol and lumin...
Figure 41: Guanidinium azacrown receptor 61 for simple amino acids and ditopic receptor 62 with crown ether an...
Figure 42: Chiral bicyclic guanidinium azacrown receptor 63 and similar receptor 64 for the enantioselective t...
Figure 43: Receptors for zwitterionic species based on luminescent CEAAs.
Figure 44: 1,10-Azacrown ethers with sugar podand arms and the anticancer agent busulfan.
Figure 45: Benzo-18-crown-6 modified β-cyclodextrin 69 and β-cyclodextrin functionalized with diaza-18-crown-6...
Figure 46: Receptors for colorimetric detection of primary and secondary ammonium ions.
Figure 47: Porphyrine-crown-receptors 72.
Figure 48: Porphyrin-crown ether conjugate 73 and fullerene-ammonium ion guest 74.
Figure 49: Calix[4]arene (75a), homooxocalix[4]arene (75b) and resorcin[4]arene (75c) compared (R = H, alkyl c...
Figure 50: Calix[4]arene and ammonium ion guest (R = H, alkyl, OAcyl etc.), possible binding sites; A: co-ordi...
Figure 51: Typical guests for studies with calixarenes and related molecules.
Figure 52: Lower rim modified p-tert-butylcalix[5]arenes 82.
Figure 53: The first example of a water soluble calixarene.
Figure 54: Sulfonated water soluble calix[n]arenes that bind ammonium ions.
Figure 55: Displacement assay for acetylcholine (3) with a sulfonato-calix[6]arene (84b).
Figure 56: Amino acid inclusion in p-sulfonatocalix[4]arene (84a).
Figure 57: Calixarene receptor family 86 with upper and lower rim functionalization.
Figure 58: Calix[6]arenes 87 with one carboxylic acid functionality.
Figure 59: Sulfonated calix[n]arenes with mono-substitution at the lower rim systematically studied on their r...
Figure 60: Cyclotetrachromotropylene host (91) and its binding to lysine (81c).
Figure 61: Calixarenes 92 and 93 with phosphonic acids groups.
Figure 62: Calix[4]arene tetraphosphonic acid (94a) and a double bridged analogue (94b).
Figure 63: Calix[4]arene tetraphosphonic acid ester (92c) for surface recognition experiments.
Figure 64: Calixarene receptors 95 with α-aminophosphonate groups.
Figure 65: A bridged homocalix[3]arene 95 and a distally bridged homocalix[4]crown 96.
Figure 66: Homocalix[3]arene ammonium ion receptor 97a and the Reichardt’s dye (97b) for colorimetric assays.
Figure 67: Chromogenic diazo-bridged calix[4]arene 98.
Figure 68: Calixarene receptor 99 by Huang et al.
Figure 69: Calixarenes 100 reported by Parisi et al.
Figure 70: Guest molecules for inclusion in calixarenes 100: DAP × 2 HCl (101a), APA (101b) and Lys-OMe × 2 HC...
Figure 71: Different N-linked peptido-calixarenes open and with glycol chain bridges.
Figure 72: (S)-1,1′-Bi-2-naphthol calixarene derivative 104 published by Kubo et al.
Figure 73: A chiral ammonium-ion receptor 105 based on the calix[4]arene skeleton.
Figure 74: R-/S-phenylalaninol functionalized calix[6]arenes 106a and 106b.
Figure 75: Capped homocalix[3]arene ammonium ion receptor 107.
Figure 76: Two C3 symmetric capped calix[6]arenes 108 and 109.
Figure 77: Phosphorous-containing rigidified calix[6]arene 110.
Figure 78: Calix[6]azacryptand 111.
Figure 79: Further substituted calix[6]azacryptands 112.
Figure 80: Resorcin[4]arene (75c) and the cavitands (113).
Figure 81: Tetrasulfonatomethylcalix[4]resorcinarene (114).
Figure 82: Resorcin[4]arenes (115a/b) and pyrogallo[4]arenes (115c, 116).
Figure 83: Displacement assay for acetylcholine (3) with tetracyanoresorcin[4]arene (117).
Figure 84: Tetramethoxy resorcinarene mono-crown-5 (118).
Figure 85: Components of a resorcinarene based displacement assay for ammonium ions.
Figure 86: Chiral basket resorcin[4]arenas 121.
Figure 87: Resorcinarenes with deeper cavitand structure (122).
Figure 88: Resorcinarene with partially open deeper cavitand structure (123).
Figure 89: Water-stabilized deep cavitands with partially structure (124, 125).
Figure 90: Charged cavitands 126 for tetralkylammonium ions.
Figure 91: Ditopic calix[4]arene receptor 127 capped with glycol chains.
Figure 92: A calix[5]arene dimer for diammonium salt recognition.
Figure 93: Calixarene parts 92c and 129 for the formation molecular capsules.
Figure 94: Encapsulation of a quaternary ammonium cation by two resorcin[4]arene molecules (NMe4+@[75c]2 × Cl−...
Figure 95: Encapsulation of a quaternary ammonium cation by six resorcin[4]arene molecules (NMe3D+@[130]6 × Cl−...
Figure 96: Structure and schematic of cucurbit[6]uril (CB[6], 131a).
Figure 97: Cyclohexanocucurbit[6]uril (CB′[6], 132) and the guest molecule spermine (133).
Figure 98: α,α,δ,δ-Tetramethylcucurbit[6]uril (134).
Figure 99: Structure of the cucurbituril-phthalhydrazide analogue 135.
Figure 100: Organic cavities for the displacement assay for amine differentiation.
Figure 101: Displacement assay methodology for diammonium- and related guests involving cucurbiturils and some ...
Figure 102: Nor-seco-Cucurbituril (±)-bis-ns-CB[6] (140) and guest molecules.
Figure 103: The cucurbit[6]uril based complexes 141 for chiral discrimination.
Figure 104: Cucurbit[7]uril (131c) and its ferrocene guests (142) opposed.
Figure 105: Cucurbit[7]uril (131c) guest inclusion and representative guests.
Figure 106: Cucurbit[7]uril (131c) binding to succinylcholine (145) and different bis-ammonium and bis-phosphon...
Figure 107: Paraquat-cucurbit[8]uril complex 149.
Figure 108: Gluconuril-based ammonium receptors 150.
Figure 109: Examples of clefts (151a), tweezers (151b, 151c, 151d) and clips (151e).
Figure 110: Kemp’s triacid (152a), on example of Rebek’s receptors (152b) and guests.
Figure 111: Amino acid receptor (154) by Rebek et al.
Figure 112: Hexagonal lattice designed hosts by Bell et al.
Figure 113: Bell’s amidinium receptor (156) and the amidinium ion (157).
Figure 114: Aromatic phosphonic acids.
Figure 115: Xylene phosphonates 159 and 160a/b for recognition of amines and amino alcohols.
Figure 116: Bisphosphonate recognition motif 161 for a colorimetric assay with alizarin complexone (163) for ca...
Figure 117: Bisphosphonate/phosphate clip 164 and bisphosphonate cleft 165.
Figure 118: N-Methylpyrazine 166a, N-methylnicotinamide iodide (166b) and NAD+ (166c).
Figure 119: Bisphosphate cavitands.
Figure 120: Bisphosphonate 167 of Schrader and Finocchiaro.
Figure 121: Tweezer 168 for noradrenaline (80b).
Figure 122: Different tripods and heparin (170).
Figure 123: Squaramide based receptors 172.
Figure 124: Cage like NH4+ receptor 173 of Kim et al.
Figure 125: Ammonium receptors 174 of Chin et al.
Figure 126: 2-Oxazolin-based ammonium receptors 175a–d and 176 by Ahn et al.
Figure 127: Racemic guest molecules 177.
Figure 128: Tripods based on a imidazole containing macrocycle (178) and the guest molecules employed in the st...
Figure 129: Ammonium ion receptor 180.
Figure 130: Tetraoxa[3.3.3.3]paracyclophanes 181 and a cyclophanic tetraester (182).
Figure 131: Peptidic bridged paraquat-cyclophane.
Figure 132: Shape-selective noradrenaline host.
Figure 133: Receptor 185 for binding of noradrenaline on surface layers from Schrader et al.
Figure 134: Tetraphosphonate receptor for binding of noradrenaline.
Figure 135: Tetraphosphonate 187 of Schrader and Finocchiaro.
Figure 136: Zinc-Porphyrin ammonium-ion receptors 188 and 189 of Mizutani et al.
Figure 137: Zinc porphyrin receptor 190.
Figure 138: Zinc porphyrin receptors 191 capable of amino acid binding.
Figure 139: Zinc-porphyrins with amino acid side chains for stereoinduction.
Figure 140: Bis-zinc-bis-porphyrin based on Tröger’s base 193.
Figure 141: BINAP-zinc-prophyrin derivative 194 and it’s guests.
Figure 142: Bisaryl-linked-zinc-porphyrin receptors.
Figure 143: Bis-zinc-porphyrin 199 for diamine recognition and guests.
Figure 144: Bis-zinc-porphyrin crown ether 201.
Figure 145: Bis-zinc-porphyrin 202 for stereodiscrimination (L = large substituent; S = small substituent).
Figure 146: Bis-zinc-porphyrin[3]rotaxane and its copper complex and guests.
Figure 147: Dien-bipyridyl ligand 206 for co-ordination of two metal atoms.
Figure 148: The ligand and corresponding tetradentate co-complex 207 serving as enantioselective receptor for a...
Figure 149: Bis(oxazoline)–copper(II) complex 208 for the recognition of amino acids in aqueous solution.
Figure 150: Zinc-salen-complexes 209 for the recognition tertiary amines.
Figure 151: Bis(oxazoline)–copper(II) 211 for the recognition of amino acids in aqueous solution.
Figure 152: Zn(II)-complex of a C2 terpyridine crown ether.
Figure 153: Displacement assay and receptor for aspartate over glutamate.
Figure 154: Chiral complex 214 for a colorimetric displacement assay for amino acids.
Figure 155: Metal complex receptor 215 with tripeptide side arms.
Figure 156: A sandwich complex 216 and its displaceable dye 217.
Figure 157: Lanthanide complexes 218–220 for amino acid recognition.
Figure 158: Nonactin (221), valinomycin (222) and vancomycin (223).
Figure 159: Monesin (224a) and a chiral analogue for enantiodiscrimination of ammonium guests (224b).
Figure 160: Chiral podands (226) compared to pentaglyme-dimethylether (225) and 18-crown-6 (4).
Figure 161: Lasalocid A (228).
Figure 162: Lasalocid derivatives (230) of Sessler et al.
Figure 163: The Coporphyrin I tetraanion (231).
Figure 164: Linear and cyclic peptides for ammonium ion recognition.
Figure 165: Cyclic and bicyclic depsipeptides for ammonium ion recognition.
Figure 166: α-Cyclodextrin (136a) and novocaine (236).
Figure 167: Helical diol receptor 237 by Reetz and Sostmann.
Figure 168: Ammonium binding spherand by Cram et al. (238a) and the cyclic[6]metaphenylacetylene 238b in compar...
Figure 169: Receptor for peptide backbone and ammonium binding (239).
Figure 170: Anion sensor principle with 3-hydroxy-2-naphthanilide of Jiang et al.
Figure 171: 7-bromo-3-hydroxy-N-(2-hydroxyphenyl)naphthalene 2-carboxamide (241) and its amine binding.
Figure 172: Naturally occurring catechins with affinity to quaternary ammonium ions.
Figure 173: Spiropyran (244) and merocyanine form (244a) of the amino acid receptors of Fuji et al.
Figure 174: Coumarin aldehyde (245) and its iminium species with amino acid bound (245a) by Glass et al.
Figure 175: Coumarin aldehyde appended with boronic acid.
Figure 176: Quinolone aldehyde dimers by Glass et al.
Figure 177: Chromogenic ammonium ion receptors with trifluoroacetophenone recognition motifs.
Figure 178: Chromogenic ammonium ion receptor with trifluoroacetophenone recognition motif bound on different m...
(Pseudo)amide-linked oligosaccharide mimetics: molecular recognition and supramolecular properties
- José L. Jiménez Blanco,
- Fernando Ortega-Caballero,
- Carmen Ortiz Mellet and
- José M. García Fernández
Beilstein J. Org. Chem. 2010, 6, No. 20, doi:10.3762/bjoc.6.20
- ranging from dimeric to octameric species (Scheme 1) [23][24]. All of these were soluble in water, DMSO and methanol, which allowed NH/ND exchange NMR experiments and circular dichroism (CD) studies to be carried out. Combined structural studies showed that a tetramer is required for an ordered secondary
Graphical Abstract
Figure 1: Schematic representation of sugar aminoacids (SAAs) and (pseudo)amide oligosaccharide mimetics.
Figure 2: Natural SAAs structures and natural nucleosidic antibiotics.
Scheme 1: Synthetic route to the target amide-linked sialooligomers. (a) Fmoc-Cl, NaHCO3, H2O, dioxane, 0 °C....
Figure 3: The general structure of glycoamino acids and their corresponding oligomers.
Figure 4: Conformational analysis of the β(1→2)-amide-linked glucooligomer 9.
Figure 5: Short oligomeric chains of C-glycosyl D-arabino THF amino acid oligomers.
Figure 6: (A) Stereoview of the minimized structure of compound 16 (produced by a 500 ps simulation) that mos...
Figure 7: Structures of linear oxetane-β- and δ-SAA homo-oligomers 19–20.
Figure 8: 10-Membered ring H-bonds in compound 21 consistent with NMR and modelling investigations.
Figure 9: General structure of carbopeptoid-oligonucleotide conjugates.
Figure 10: Protected derivatives of 2,6-diamino-2,6-dideoxy-β-D-glucopyranosyl carboxylic acid 22 and 23.
Figure 11: Cyclic homo-oligomers containing glucopyranoid-SAAs.
Scheme 2: Strategy for solid-phase synthesis of cyclic trimers and tetramers containing pyranoid δ-SAAs.
Figure 12: Cyclic tetramers of L-rhamno- and D-gulo-configured oxetane-SAAs.
Figure 13: Aminoglycosidic antibiotics of the glycocinnamoylspermidine family.
Scheme 3: Synthesis of (thio)trehazoline, via triflate, from β-hydroxy(thio)urea.
Figure 14: Approaches to access pseudoamide-type oligosaccharide mimics.
Figure 15: Calystegine B2 analogues 38 and 39 with urea-linked disaccharide structure.
Figure 16: Rotameric equilibrium shift of 40 by formation of a bidentate hydrogen bond.
Figure 17: Nucleotide analogues with thiourea and S-methylisothiouronium linkers.
Scheme 4: Retrosynthetic approach to synthesize thiourea-linked glycooligomers.
Figure 18: Rotameric equilibria for β-(1→6)-thiourea-linked glucodimer 41.
Figure 19: Schematic representation of (a) cyclodextrin (CDs) and (b) cyclotrehalan (CTs) family members.
Scheme 5: Synthesis of guanidine-linked pseudodisaccharides via carbodiimide.
Figure 20: β(1→6)-Guanidine-linked pseudodi- and pseudotrisaccharides 47 and 48.
Scheme 6: Synthesis of N-benzylguanidine-linked CT2 50.
Figure 21: Structure of RNG and DNG.
Figure 22: Preparation of Fmoc-guanidinium derivatives.
Figure 23: Structures of the homo-oligomeric RNG derivatives 51–55.
Figure 24: Phosphoramidite building block 56.
Figure 25: Structures of DNGs 57–65.
Figure 26: Structure of the phosphoramidite building block 66.
Ring strain and total syntheses of modified macrocycles of the isoplagiochin type
- Andreas Speicher,
- Timo Backes,
- Kerstin Hesidens and
- Jürgen Kolz
Beilstein J. Org. Chem. 2009, 5, No. 71, doi:10.3762/bjoc.5.71
- and quantum chemical CD (circular dichroism) investigations, the absolute configuration of the first natural compound of this type, isoplagiochin C from P. deflexa, was established as (PA)-1 and the energy of racemization was calculated and measured to be 102 kJ/mol, approximately [13]. The
Graphical Abstract
Figure 1: Structures of isoplagiochins C (1) and D (2) (with aryl fragments a–d and possible conformational b...
Figure 2: Possible stereoisomers of 1 as conformers C1–C4 relative to the configurationally stable biaryl axi...
Scheme 1: Stereochemical correlation for 1 and 2. (*: configurationally stable, (*): configurationally semi-s...
Figure 3: Temperature dependent 1H NMR and assignment of methoxy signals in the tetramethyl ether 3.
Scheme 2: Strategy of synthesis for the macrocycles 5–7.
Scheme 3: Preparation of the terminal alkyne 13 as a–b part (TBATB = tetrabutylammonium tribromide).
Scheme 4: Sonogashira-type coupling to the tolane 16.
Scheme 5: Synthesis of the d building blocks 21 and 26. aThe original procedure in diluted ammonia [31] was repla...
Scheme 6: Synthesis of the tolane precursors 27 and 28 for cyclization.
Scheme 7: Synthesis of the modified macrocycles 5–7 from the dialdehyde precursors 28–30.
Scheme 8: Synthesis of the known macrocycle 3 via McMurry reaction.
Chiral amplification in a cyanobiphenyl nematic liquid crystal doped with helicene-like derivatives
- Alberta Ferrarini,
- Silvia Pieraccini,
- Stefano Masiero and
- Gian Piero Spada
Beilstein J. Org. Chem. 2009, 5, No. 50, doi:10.3762/bjoc.5.50
- papers, see refs [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21]). Cholesteric induction has also been exploited for the assignment of the absolute configuration of chiral molecules, as a viable alternative or complement to more usual techniques such as Circular Dichroism [2][3] (for a
Graphical Abstract
Figure 1: Schematic structure of a right-handed chiral nematic (cholesteric) phase. Black arrows represent th...
Figure 2: Structures of the dopants investigated.
Figure 3: Geometry of dopants 1–8. Structures were obtained from DFT calculations at the B3LYP/6-31g** level [58]...
Figure 4: Helicity of the molecular surface of derivative 1 along its principal alignment axes in the liquid ...
Recent progress on the total synthesis of acetogenins from Annonaceae
- Nianguang Li,
- Zhihao Shi,
- Yuping Tang,
- Jianwei Chen and
- Xiang Li
Beilstein J. Org. Chem. 2008, 4, No. 48, doi:10.3762/bjoc.4.48
Graphical Abstract
Scheme 1: Total synthesis of longifolicin by Marshall’s group.
Scheme 2: Total synthesis of corossoline by Tanaka’s group.
Scheme 3: Total synthesis of corossoline by Wu’s group.
Scheme 4: Total synthesis of pseudo-annonacin A by Hanessian’s group.
Scheme 5: Total synthesis of tonkinecin by Wu’s group.
Scheme 6: Total synthesis of gigantetrocin A by Shi’s group.
Scheme 7: Total synthesis of annonacin by Wu’s group.
Scheme 8: Total synthesis of solamin by Kitahara’s group.
Scheme 9: Total synthesis of solamin by Mioskowski’s group.
Scheme 10: Total synthesis of cis-solamin by Makabe’s group.
Scheme 11: Total synthesis of cis-solamin by Brown’s group.
Scheme 12: The formal synthesis of (+)-cis-solamin by Donohoe’s group.
Scheme 13: Total synthesis of cis-solamin by Stark’s group.
Scheme 14: Total synthesis of mosin B by Tanaka’s group.
Scheme 15: Total synthesis of longicin by Hanessian’s group.
Scheme 16: Total synthesis of murisolin and 16,19-cis-murisolin by Tanaka’s group.
Scheme 17: Synthesis of a stereoisomer library of (+)-murisolin by Curran’s group.
Scheme 18: Total synthesis of murisolin by Makabe’s group.
Scheme 19: Total synthesis of reticulatain-1 by Makabe’s group.
Scheme 20: Total synthesis of muricatetrocin C by Ley’s group.
Scheme 21: Total synthesis of (4R,12S,15S,16S,19R,20R,34S)-muricatetrocin (146) and (4R,12R,15S,16S,19R,20R,34S...
Scheme 22: Total synthesis of parviflorin by Hoye’s group.
Scheme 23: Total synthesis of parviflorin by Trost’s group.
Scheme 24: Total synthesis of trilobacin by Sinha’s group.
Scheme 25: Total synthesis of 15-epi-annonin I 181b by Scharf’s group.
Scheme 26: Total synthesis of squamocin A and squamocin D by Scharf’s group.
Scheme 27: Total synthesis of asiminocin by Marshall’s group.
Scheme 28: Total synthesis of asiminecin by Marshall’s group.
Scheme 29: Total synthesis of (+)-(30S)-bullanin by Marshall’s group.
Scheme 30: Total synthesis of uvaricin by the group of Sinha and Keinan.
Scheme 31: Formal synthesis of uvaricin by Burke’s group.
Scheme 32: Total synthesis of trilobin by Marshall’s group.
Scheme 33: Total synthesis of trilobin by the group of Sinha and Keinan.
Scheme 34: Total synthesis of asimilobin by the group of Wang and Shi.
Scheme 35: Total synthesis of squamotacin by the group of Sinha and Keinan.
Scheme 36: Total synthesis of asimicin by Marshall’s group.
Scheme 37: Total synthesis of asimicin by the group of Sinha and Keinan.
Scheme 38: Total synthesis of asimicin by Roush’s group.
Scheme 39: Total synthesis of asimicin by Marshall’s group.
Scheme 40: Total synthesis of 10-hydroxyasimicin by Ley’s group.
Scheme 41: Total synthesis of asimin by Marshall’s group.
Scheme 42: Total synthesis of bullatacin by the group of Sinha and Keinan.
Scheme 43: Total synthesis of bullatacin by Roush’s group.
Scheme 44: Total synthesis of bullatacin by Pagenkopf’s group.
Scheme 45: Total synthesis of rollidecins C and D by the group of Sinha and Keinan.
Scheme 46: Total synthesis of 30(S)-hydroxybullatacin by Marshall’s group.
Scheme 47: Total synthesis of uvarigrandin A and 5(R)-uvarigrandin A by Marshall’s group.
Scheme 48: Total synthesis of membranacin by Brown’s group.
Scheme 49: Total synthesis of membranacin by Lee’s group.
Scheme 50: Total synthesis of rolliniastatin 1 and rollimembrin by Lee’s group.
Scheme 51: Total synthesis of longimicin D by the group of Maezaki and Tanaka.
Scheme 52: Total synthesis of the structure proposed for mucoxin by Borhan’s group.
Scheme 53: Modular synthesis of adjacent bis-THF annonaceous acetogenins by Marshall’s group.
Scheme 54: Total synthesis of 4-deoxygigantecin by Tanaka’s group.
Scheme 55: Total synthesis of squamostatins D by Marshall’s group.
Scheme 56: Total synthesis of gigantecin by Crimmins’s group.
Scheme 57: Total synthesis of gigantecin by Hoye’s group.
Scheme 58: Total synthesis of cis-sylvaticin by Donohoe’s group.
Scheme 59: Total synthesis of 17(S),18(S)-goniocin by Sinha’s group.
Scheme 60: Total synthesis of goniocin and cyclogoniodenin T by the group of Sinha and Keinan.
Scheme 61: Total synthesis of jimenezin by Takahashi’s group.
Scheme 62: Total synthesis of jimenezin by Lee’s group.
Scheme 63: Total synthesis of jimenezin by Hoffmann’s group.
Scheme 64: Total synthesis of muconin by Jacobsen’s group.
Scheme 65: Total synthesis of (+)-muconin by Kitahara’s group.
Scheme 66: Total synthesis of muconin by Takahashi’s group.
Scheme 67: Total synthesis of muconin by the group of Yoshimitsu and Nagaoka.
Scheme 68: Total synthesis of mucocin by the group of Sinha and Keinan.
Scheme 69: Total synthesis of mucocin by Takahashi’s group.
Scheme 70: Total synthesis of (−)-mucocin by Koert’s group.
Scheme 71: Total synthesis of mucocin by the group of Takahashi and Nakata.
Scheme 72: Total synthesis of mucocin by Evans’s group.
Scheme 73: Total synthesis of mucocin by Mootoo’s group.
Scheme 74: Total synthesis of (−)-mucocin by Crimmins’s group.
Scheme 75: Total synthesis of pyranicin by the group of Takahashi and Nakata.
Scheme 76: Total synthesis of pyranicin by Rein’s group.
Scheme 77: Total synthesis of proposed pyragonicin by the group of Takahashi and Nakata.
Scheme 78: Total synthesis of pyragonicin by Rein’s group.
Scheme 79: Total synthesis of pyragonicin by Takahashi’s group.
Scheme 80: Total synthesis of squamostanal A by Figadère’s group.
Scheme 81: Total synthesis of diepomuricanin by Tanaka’s group.
Scheme 82: Total synthesis of (−)-muricatacin [(R,R)-373a] and its enantiomer (+)-muricatacin [(S,S)-373b] by ...
Scheme 83: Total synthesis of epi-muricatacin (+)-(S,R)-373c and (−)-(R,S)-373d by Scharf’s group.
Scheme 84: Total synthesis of (−)-muricatacin 373a and 5-epi-(−)-muricatacin 373d by Uang’s group.
Scheme 85: Total synthesis of four stereoisomers of muricatacin by Yoon’s group.
Scheme 86: Total synthesis of (+)-muricatacin by Figadère’s group.
Scheme 87: Total synthesis of (+)-epi-muricatacin and (−)-muricatacin by Couladouros’s group.
Scheme 88: Total synthesis of muricatacin by Trost’s group.
Scheme 89: Total synthesis of (−)-(4R,5R)-muricatacin by Heck and Mioskowski’s group.
Scheme 90: Total synthesis of muricatacin (−)-373a by the group of Carda and Marco.
Scheme 91: Total synthesis of (−)- and (+)-muricatacin by Popsavin’s group.
Scheme 92: Total synthesis of (−)-muricatacin by the group of Bernard and Piras.
Scheme 93: Total synthesis of (−)-muricatacin by the group of Yoshimitsu and Nagaoka.
Scheme 94: Total synthesis of (−)-muricatacin by Quinn’s group.
Scheme 95: Total synthesis of montecristin by Brückner’s group.
Scheme 96: Total synthesis of (−)-acaterin by the group of Franck and Figadère.
Scheme 97: Total synthesis of (−)-acaterin by Singh’s group.
Scheme 98: Total synthesis of (−)-acaterin by Kumar’s group.
Scheme 99: Total synthesis of rollicosin by Quinn’s group.
Scheme 100: Total synthesis of Rollicosin by Makabe’s group.
Scheme 101: Total synthesis of squamostolide by Makabe’s group.
Scheme 102: Total synthesis of tonkinelin by Makabe’s group.
